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Cytoskeletal Components Define Protein
Location to Membrane Microdomains*□S
Witold G. Szymanski‡, Henrik Zauber§, Alexander Erban‡, Michal Gorka‡, Xu Na Wu‡,
and Waltraud X. Schulze¶
The plasma membrane is an important compartment
that undergoes dynamic changes in composition upon
external or internal stimuli. The dynamic subcompart-
mentation of proteins in ordered low-density (DRM) and
disordered high-density (DSM) membrane phases is hy-
pothesized to require interactions with cytoskeletal
components. Here, we systematically analyzed the ef-
fects of actin or tubulin disruption on the distribution of
proteins between membrane density phases. We used a
proteomic screen to identify candidate proteins with
altered submembrane location, followed by biochemical
or cell biological characterization in Arabidopsis thali-
ana. We found that several proteins, such as plasma
membrane ATPases, receptor kinases, or remorins re-
sulted in a differential distribution between membrane
density phases upon cytoskeletal disruption. Moreover,
in most cases, contrasting effects were observed: Dis-
ruption of actin filaments largely led to a redistribution
of proteins from DRM to DSM membrane fractions while
disruption of tubulins resulted in general depletion of
proteins from the membranes. We conclude that actin
filaments are necessary for dynamic movement of pro-
teins between different membrane phases and that
microtubules are not necessarily important for forma-
tion of microdomains as such, but rather they may
control the protein amount present in the membrane
phases. Molecular & Cellular Proteomics 14: 10.1074/
mcp.M114.046904, 2493–2509, 2015.
Living cells need borders and molecular compartments for
biochemical reactions and storage of metabolites. The
plasma membrane therefore is a prerequisite for the evolution
of different life forms. It consists of a phospholipid bilayer into
which proteins and special lipid species such as sterols,
sphingolipids, and glycolipids are inserted. The first complex
model of plasma membrane was proposed in 1972 by Jona-
than Singer and Garth Nicolson (1), replacing the concept of
the plasma membrane as a strict protein–lipid–protein sand-
wich that was generally accepted until then. In Singer and
Nicolson’s model, the cell membrane is a two-dimensionally
oriented viscous solution in which the membrane constituents
are orientated in the most thermodynamically favorable man-
ner, hiding hydrophobic hydrocarbon chains inside the lipid
bilayer and exposing polar and ionic groups to the aqueous
phase. This fluid mosaic model also implied that membrane
proteins as well as lipid components are distributed in a
homogeneous lipid bilayer at long range, but they can form
specific aggregates and phases at short range, which were
also termed “lipid rafts” or membrane microdomains.
Over the past 30 years, it has become evident that the
plasma membrane is not such a homogeneous structure as it
was initially proposed. We now know that the lipid bilayer is
asymmetric (2) and that the free diffusion of membrane pro-
teins is restricted by their interactions with intracellular and
extracellular components (3). More recently, Simons and
Ikonen suggested that large ordered phases, enriched with
cholesterol and sphingolipids, emerge within the plasma
membrane and that they function as platforms for enrichment
of certain proteins while excluding others (4). This current
membrane model suggests that the mixture of sterols and
polar lipids within the plasma membrane can appear in two
distinct phases: liquid disordered (Ld) and liquid ordered (Lo)
phase (5). In this view, the so-called membrane microdomains
are considered to be part of the Lo phase. Based on work on
model membranes, it is suggested that lateral segregation of
components into Ld and Lo phases occurs spontaneously (6)
with the self-associating properties between sterols and
highly saturated hydrocarbon chains of phopsho- and sphin-
golipids as the main driving force (7). Additionally, it is sug-
gested that also specific lipid-protein and protein-protein in-
teractions are essential for the formations of membrane
domains as well as for stabilization of smaller nanodomains
which subsequently may cause formation of larger platforms.
In contrast to the animal cells, in plants these membrane
microdomains seem to be rather immobile (8), possibly due to
their attachment to the outer cell wall. More recently, it be-
came obvious that membrane microdomains within a single
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cell are highly diverse and of different compositions (9). Gen-
erally, in the plant model, organisms’ plasma membrane mi-
crodomains turned out to be important in plant defense (10,
11), cell polarity (12, 13), and general signaling properties of
the plasma membrane (14, 15).
The cytoskeleton was identified as an essential cellular
component with important roles in membrane topography,
bordering, trafficking, and organelle movement (16). Single
particle tracking in mammalian cells revealed that the trans-
ferrin receptor and macroglobulin receptor demonstrate nor-
mal Brownian diffusion but only within a specific membrane
compartment (17). Two hypothetical models were proposed in
order to explain this phenomenon (supplemental Fig. 1). Di-
rect interactions between transmembrane proteins and cyto-
skeleton are suggested to creates a barrier, called “fence,”
where cytosolic parts of transmembrane proteins collides with
cytoskeletal components, limiting their diffusion to certain
areas. These molecules can jump over the “fence” to a neigh-
boring compartment, possibly due to the dynamic nature of
the interaction of membrane proteins and cytoskeleton, where
they are again temporally trapped (17). This phenomenon was
recently described also in A. thaliana where the interplay
between membrane microdomains and microtubules plays a
role in secondary cell wall formation (reviewed in (18)). The
second model assumes, additionally, that particular trans-
membrane proteins are anchored to and lined up along cyto-
skeleton and act as “pickets” to arrest free diffusion of other
membrane components, including nontransmembrane pro-
teins, within the enclosed compartment (19).
For plants, the composition of these sterol-rich membranes
phases was analyzed in several biochemical studies (14, 20–
22). Thereby, low-density preparations of plasma membrane
fractions after treatment with nonionic detergents (DRM1 frac-
tions) were considered as a biochemical representation en-
riched in cellular membrane ordered phases or microdomains.
Proteomic studies in mammalian cells consistently reported
that the DRM fraction is highly enriched with several cytoskel-
etal proteins such as actin, tubulin, myosin, dynamin, actinin,
and supervillin (23–25). Additionally, the level of phosphatidyl-
inositol 4,5-bisphosphate (PI(4,5)P2), a lipid connecting the
plasma membrane to actin filaments, was also significantly
elevated in DRM preparations (26). Treatment with microtu-
bule and actin depolymerizing agent results in drastic loss of
many signaling proteins from these DRM fractions prepared
from adult rat cardiac myocytes (27) or human embryonic
retinal cells (28).
Based on this knowledge, we propose two hypothetical
models for the relationship between cytoskeleton and mem-
brane microdomains for plant cells: (i) Actin filaments and
microtubules could be important in the membrane phase
separation or formation of the membrane microdomains
themselves. In this case, disruption of the cytoskeleton would
cause a lack of phase segregation in the plasma membrane.
(ii) The cytoskeleton is only important for the incorporation of
specific protein into the sterol-enriched regions but not for the
general formation of these phase separations. This view im-
plies that phase separations or membrane microdomains
would still be present after cytoskeleton disruption but their
protein composition can be different. Another possible sce-
nario is (iii) that cytoskeletal elements serve as anchors for
membrane microdomains at particular position in the plasma
membrane, so the absence of these anchors would cause the
increased mobility of microdomains (supplemental Fig. 1).
The primary aim of this study was to characterize the inter-
play between cytoskeletal components and different mem-
brane phases (microdomains) in A. thaliana suspension cell
cultures. To reach this goal, biochemical and proteomic ap-
proaches were combined with confocal microscopy and ac-
tivity assays measuring the influence of actin or tubulin dis-
ruption on the composition, localization, and biochemical
properties of the sterol-enriched membrane microdomains.
Thereby, for biochemical analyses, low-density detergent-
resistant membrane fractions are analyzed as containing cel-
lular sterol-rich membrane compartments.
MATERIALS AND METHODS
Plant Lines Expressing Proteins Fused to GFP/YFP/RFP—Seeds of
an A. thaliana complementation line with YFP-tagged (yellow fluores-
cent protein) remorin 1.2 based on SALK line 117637 were obtained
as a courtesy of Dr. Thomas Ott from Ludwig Maximilian University of
Munich, Germany. Homozygous lines of A. thaliana expressing GFP-
tagged leucin-rich repeat receptor-like kinase (LRR-RLK)
At3G02880.1 under 35S promoter were obtained as a courtesy from
Xuna Wu, University of Hohenheim, Germany.
Seeds of an A. thaliana dual-labeled line for actin and tubulin were
obtained as a courtesy of AG Persson from the Max Planck Institute
of Molecular Plant Physiology in Golm, Germany. This line allowed
observation of the structure of microtubules and actin filaments in the
same plant at the same time. The dual-labeled line was created by
transformation of Col-0 with pART27 vector containing GFP-FABD2
fusion construct under 35S promoter together with a gene for kana-
mycin resistance (29). This line was subsequently crossed with an-
other line that was transformed with a Gateway vector containing
TUA5 fused to mCherry-RFP under 35S promoter together with genes
for kanamycin resistance (30).
Seedlings—Sterilized seeds of YFP-tagged remorin lines were
grown on 1/2 Murashige–Skoog medium containing 1.5% agarose,
1% sucrose, and kanamycin. Seedlings transferred on plates were left
for 5 days in a light-dark cycle with a 16-h photoperiod at 23 °C. Prior
to the performed experiments, seedlings were carefully moved into
the cavity of a six-well plate filled with 1/2 liquid MS medium with 1%
sucrose and placed on a rotary shaker (50 rpm).
Cell Suspension Cultures—Cell suspension cultures were estab-
lished from A. thaliana Col-0 leaf callus as described (31). They were
grown in flasks in full JPL medium under constant light conditions at
80–100 mol m2s1 at 23 °C with rotary shaking at 120 rpm. Cells
were subcultured every 7 days. In order to perform experiments, cell
cultures were pooled from and independent flask and subsequently
divided into desired numbers of replicates for treatment. In general,
1 The abbreviations used are: DRM, detergent-resistant membrane
fraction; DSM, detergent-soluble membrane fraction; ER, endoplas-
mic reticulum; PM, plasma membrane.
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treatment experiments were carried out in at least three biological
replicates, and results are presented as an average of these.
Treatment with Cytoskeleton Depolymerizing Agents—Experiments
were performed with cytochalasin D, which is a potent inhibitor of
actin polymerization. Cytochalasin D binds to G-actin and prevents
polymerization of actin monomers (32), as well as to the barbed end
of actin filaments, which inhibits the association of hew monomers at
that end (33). The second drug used in the experiments was oryzalin
(3,5-dinitro-N4, N4-dipropylsulfanilimide), which is a selective pre-
emergence, surface-applied dinitroaniline herbicide with rather low
toxicity to animals and fungi. This drug acts as a microtubule depo-
lymerizing agent, and it perturbs all microtubule-related processes in
plant cells (34, 35). Both inhibitory effects were shown to be reversible
(36). Stock solutions of cytochalasin D and oryzalin were dissolved in
DMSO. The following experimental conditions were applied:
Cytochalasin D treatment: Cells treated with cytochalasin D may
react to the loss of the links between the plasma membrane and actin
filaments by creating more filaments that might compensate for the
initial depolymerizing effect of cytochalasin D (37). In order to evaluate
this effect, time points instead of different concentrations were used.
Cell cultures were treated with cytochalasin D in concentration of 500
nM for different periods: 30 min, 60 min, 90 min, and 120 min. The
concentration used was far lower than the minimal concentration
known to disrupt cytoplasmic streaming (38). Control samples were
treated with respective volumes of DMSO solution. The concentration
of DMSO in final solutions was not higher than 0.1%. After treatment,
cells were filtered and immediately frozen in liquid nitrogen.
Oryzalin treatment: According to the literature, oryzalin has an
impact on the normal structure of the microtubules already at nano-
molar concentrations but often requiring long exposure (34, 35). In
order to perform experiments at similar time frames as the cytocha-
lasin D treatment, we selected increasing oryzalin concentrations
applied for the duration of 1 h. Cell cultures were treated with different
concentrations of oryzalin (1 M, 2 M, 5 M, and 10 M) for 1 h.
Instead of a disrupting agent, respective amount of DMSO was added
to control samples. The concentration of DMSO in final solutions was
not higher than 0.1%. After treatment, cells were filtered and imme-
diately frozen in liquid nitrogen.
Enzyme Activity Measurements—Activity of the plasma membrane
H-ATPase in DRM and DSM fractions was measured by the mala-
chite green colorimetric assay (39). The standardization of different
samples was based on total protein content, which was evaluated by
the NanoOrange Protein Quantitation Kit (Invitrogen, Germany) ac-
cording to the instructions. Specific inhibitors of P-type and V-type
ATPases were used to distinguish the specific activity of selected
enzyme from the background activity of the sample: Na3VO4 as
plasma membrane ATPase inhibitor, EDTA as inhibition of Ca2-
ATPases, NaN3 as inhibition of mitochondrial ATPases, and bafilomy-
cin A1 as inhibitor of V-ATPases (40).
In order to perform enzymatic activity measurement, 1 g of ex-
tracted protein was used per reaction mixture. The plate was placed
on a shaker at 37 °C. Reaction was stopped after 1 or 2 h by adding
MG-AM-TRIT [three volumes of MG solution (2 mM malachite green in
Milipore water) and one volume of AM solution (0.034 M ammonium
molybdate in 4 N HCl, 0.1% Triton X-100) solution to each well.
Addition of sodium citrate to a final concentration of 3% inhibited the
color development. The change in phosphate concentration was
measured by absorption using the wavelength of 630 nm.
Preparation of Membrane Fractions for Proteomic Analysis—In
general, microsomal fractions, plasma membrane, and DRM/DSF
fractions were prepared as described in detail (41). Frozen plant
material was powderized, mixed with two volumes of extraction buffer
(100 mM Hepes-KOH (pH 7.5); 250 mM sucrose; 10% (w/v) glycerol; 5
mM EDTA; 5 mM ascorbic acid; 0.6% (w/v) PVP K-25; freshly added:
5 mM DTT; 1 mM PMSF; protease inhibitor mixture (SIGMA, Ger-
many)), and stirred gently on ice until complete homogenization was
achieved. The homogenate was then filtered through one layer of
Miracloth (Merck, Germany), and cell debris was spun down at 10,000
g for 8 min. The supernatant was taken and centrifuged at 100,000 g
for 30 min. After this step, microsomes were acquired in the pellet and
soluble proteins (SOL fraction) in supernatant (Fig. 1). The microsomal
fraction was solubilized in resuspension buffer (5 mM potassium
phosphate; 0.33 M sucrose; 3 mM KCl; 0.1 mM EDTA; freshly added:
1 mM DTT, 1 mM PMSF) and then deposited onto a two-phase system
of polyethyleneglycol and dextran (41). After gentle mixing and cen-
trifugation at 1,000 g for 10 min, the lower green phase contained
intracellular membranes (IM fraction) while the upper phase contained
cell plasma membrane (PM fraction). The latter was collected, diluted
with five volumes of resuspension buffer and centrifuged again at
200,000 g for 1 h. The obtained pellet was then resuspended in TNE
buffer (25 mM Tris-HCl pH 7.5; 150 mM NaCl; 5 mM EDTA; 1 mM DTT),
and protein concentration was measured using Bradford assay (42).
At this step, an aliquot of the plasma membrane protein was taken for
analysis (Fig. 1).
Solubilized in TNE buffer, the plasma membrane was subsequently
treated with Triton X-100 in a concentration between 0.5 and 1% and
in a ratio of proteins to Triton of 1:15. The detergent treatment was
applied for 30 min on ice with shaking. Detergent-resistant and de-
tergent-soluble membranes created after Triton X-100 were sepa-
rated by centrifugation for 18 h through a sucrose step gradient (from
the bottom: 1.8 M, 1.6 M, 1.4 M, 0.15 M). After centrifugation, a
low-density band was observed as a white ring at the interface of the
0.15 M and 1.4 M sucrose phases (41). A fraction of 1 ml containing the
ring was collected as DRM fraction, and 1 ml from the bottom of
the gradient was collected as DSM fraction.
Recovery of Proteins from the Sucrose Gradient—For mass spec-
trometry: Proteins from collected fractions were purified by methanol-
chloroform method. Initially, four volumes of methanol, one volume of
chloroform, and three volumes of water were added to the sample,
and after each addition, the sample was vortexed. Next, the sample
was centrifuged for 15 min at room temperature. The upper phase
was removed, and the lower phase was diluted with three volumes of
FIG. 1. Protein fractionation and analysis scheme. During isola-
tion of DRM other protein fractions were collected, including soluble
proteins, internal membranes, and DSM, which were all subsequently
analyzed by a combination of different biochemical and mass spec-
trometry methods.
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methanol. Protein was then pelleted by centrifugation for 15 min at
maximum speed (20,800 g).
For enzymatic measurements: The recovery of proteins from col-
lected sucrose gradient fractions was based on dissolving the dense
sucrose with large volumes of buffer TNE and subsequently pelleting
membranes by ultracentrifugation at 200,000 g for 1 h.
In Solution Protein Digestion and Desalting—Purified proteins from
preceding steps were dissolved in 6 M urea/2 M thiourea, pH 8, which
causes denaturation of proteins. Subsequently, disulfide bonds were
released by treatment with DTT, and spontaneous oxidation was
prevented by carbamidomethylation with iodoacetamide. Lys-C and
trypsin were applied for the digestion of proteins and creation of
low-molecular-weight tryptic peptides as described (41). After trypsin
digestion, samples were desalted on C18 Stop And Go Extraction tips
(C18 Empore Disks, 3 M) (43), dried in a vacuum concentrator, and
resuspended in 1% trifluoroacetic acid, 5% acetonitrile just before
loading onto the liquid chromatography column.
LC-MS/MS Analysis of Peptides—Digested and desalted peptides
were analyzed by LC/MS/MS using nanoflow HPLC (Easy nLC,
Thermo Scientific) and an Orbitrap hybrid mass spectrometer (LTQ-
Orbitrap XL, Thermo Scientific) as mass analyzer. Peptides were
eluted from a 15 cm long, 75 m wide analytical column filled with C18
beads (Reprosil C18, Dr. Maisch GmbH, Germany) on a linear gradi-
ent running from 5% to 80% acetonitrile in 90 min at a flow rate of 250
nl/min and sprayed directly into the mass spectrometer. Proteins
were identified by tandem mass spectrometry (MS/MS) by informa-
tion-dependent acquisition of fragmentation spectra of multiple-
charged peptides. Up to five data-dependent MS/MS spectra were
acquired in the linear ion trap for each FTMS full scan spectrum
acquired at 60,000 full-width half-maximum resolution settings with
an overall cycle time of 1 s.
For raw file peak extraction and protein identification, we used
MaxQuant software (44) (version 1.4.2.1) with A. thaliana TAIR10
protein sequences (35,386 entries) used by the search engine An-
dromeda (45). The following additional parameters were applied: tryp-
sin as cleaving enzyme; 10 ppm peptide mass tolerance; 0.8 Da
MS/MS tolerance; maximal two missed cleavages allowed, threshold
for validation of peptides set to 0.01 using a decoy database, acety-
lation at N-terminal of proteins, and oxidation of methionine set as
variable modification, carbamidomethylation of cysteine set as a fixed
modification, “label-free quantification” marked, “match between
runs” marked, minimum peptide length of six amino acids, and re-
tention time correlation enabled (time window of 2 min). Spectra of
identified peptides are available in supplemental Fig. 2. Known con-
taminants, such as keratins, were excluded from further analysis.
Label-Free Protein Intensities Calculation—Peptide lists derived
from MaxQuant (evidence.txt) were processed by an R-based script
(cRacker (46)) allowing for automated and standardized processing.
Peptides with the assigned MaxQuant score below 30 and peptides
that were quantified in less than 90% of all fraction-specific samples
were filtered out. The principal steps of the normalization and quan-
titation were: (i) All peptide intensities within each sample were nor-
malized to fraction of total ion-intensity sums. (ii) To compensate
effects of normalization due to the number of detected peptides per
sample, intensity was proportionally corrected to the reciprocal num-
ber of identified peptides in each sample using the integrated nor-
malization option in cRacker. (iii) Peptide intensities with missing
values in more than the permitted numbers of samples within repli-
cates of each fraction were filtered out. (iv) Outliers exclusion was
used to lower the influence of extreme peptide intensity values on the
average protein intensity. (v) Remaining normalized peptide intensities
were z-score scaled and mean averaged.
Protein Gel Blots—Protein concentration in different fractions after
chloroform/methanol extraction was evaluated by NanoOrange (Invit-
rogen) according to the instructions and equal amounts of proteins
(10 g) per sample were loaded onto 10% polyacrylamide gels.
SDS-polyacrylamide gel electrophoresis and protein gel blots were
performed as described (47). The membrane was blocked in blocking
solution overnight at 4 °C and was subsequently washed three times
with PBS-T (0.2% Tween-20, 10 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, and 2 mM KH2PO4, pH 7.4) and later incubated with the
primary antibody GFP at the concentration of 1:10,000 in PBS-T for
1 h at room temperature. After additional washing steps, the second-
ary antibody alkaline phosphatase coupled anti-mouse IgG was used
at the concentration of 1:10,000 in PBS-T for 1 h at room temperature.
For detection of the signal, blots were incubated in alkaline phospha-
tase-detection buffer (pH 9.5) with addition of 5-bromo-4-chloro-3-
indolyphosphate p-toluidine salt and nitro-blue tetrazolium chloride.
Extraction of Lipids—After density gradient centrifugation for the
separation of DRM and DSM, a volume of 1 ml for the low-density
band (DRM) as well as 1 ml from the bottom of the gradient (DSM) was
transferred to the clean 15 ml falcon tube. For each 1 ml of sample, 5
l of 5 mM 3-hydroxy-5-cholestane (cholestanol) was added, which
reflected 10 g of this compound and served as an internal standard.
Lipids were extracted by the chloroform-methanol method (48). To
each sample 3.75 ml of 1:2 (v/v) CHCl3:CH3OH were added, then 1.25
ml of CHCl3, and finally 1.25 ml of water. Tubes were vortexed
thoroughly after each solvent addition. The final mixture was centri-
fuged at 200 g for 5 min at room temperature, which resulted in a
separation into upper aqueous and bottom organic phases. The
aqueous solution was removed using a Pasteur pipette, and the
organic phase was washed with “authentic upper phase” (prepared
by performing blank chloroform-methanol extraction on water). The
cleaned organic phase was subsequently transferred in batches of
500 l to a smaller tube and dried in a vacuum concentrator. By
repeatedly drying down small volumes, the spread of extracted lipids
around the whole inner surface of the tube was minimized.
Metabolite Profiling—The profiling of soluble metabolites was per-
formed as described previously (49) by gas chromatography coupled
to electron impact ionization/time-of-flight mass spectrometry (GC-
EI/TOF-MS). Dried lipid species were methoxyaminated and trimeth-
ylsilylated manually prior to GC-EI/TOF-MS analysis. Analysis was
performed using an Agilent 6890N24 gas chromatograph (Agilent
Technologies, Boeblingen, Germany) with splitless injection onto a
FactorFour VF-5ms capillary column, 30 m length, 0.25 mm inner
diameter, 0.25 m film thickness (Varian-Agilent Technologies) con-
nected to a Pegasus III time-of-flight mass spectrometer (LECO In-
strumente GmbH, Moenchengladbach, Germany). Retention indices
were calibrated by addition of a C10, C12, C15, C18, C19, C22, C28, C32,
and C36 n-alkane mixture to each sample (50).
GC-EI/TOF-MS chromatograms were acquired, visually controlled,
baseline corrected, and exported in NetCDF file format using Chro-
maTOF software (Version 4.22; LECO, St. Joseph, MI). GC-MS data
processing into a standardized numerical data matrix and compound
identification were performed using the TagFinder software (51, 52).
Compounds were identified by mass spectral and retention time
index matching to the reference collection of the Golm metabolome
database (http://gmd.mpimpgolm.mpg.de/) (53–55). Guidelines for
manually supervised metabolite identification were the presence of at
least three specific mass fragments per compound and a retention
index deviation within 1.0%. All mass features of an experiment were
normalized by sample fresh weight, internal standard (C22), and were
then maximum scaled.
Confocal Microscopy—Fluorescence imaging shown in the study
was performed as described below. The fluorescent signal of GFP,
YFP, and mCherry was recorded using Leica TCS-SP2 system cou-
pled with DM6000 inverted light microscope and HCX PL APO 63.0
1.20 W CORR objective. The excitation was achieved using 488 nm
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argon laser for GFP, 514 nm argon laser for YFP, and 561 nm diode
laser for mCherry. Resulting emission was separated using triple
dichroic TD 488/543/633 for GFP, dichroic RSP 500 for YFP, and
double dichroic DD488/543 for mCherry. Separated light was col-
lected and amplified using PMT detectors between 502–550 nm for
GFP, 505–550 for YFP, and 577–650 nm for mCherry. Images were
acquired with resolution of 1,024  1,024 pixels. Pinhole was set
between 0.295 and 1 Airy unit.
Statistical Analyses and Data Visualization—All statistical tests on
proteomic data, such as hierarchical clustering and k-means cluster-
ing, were automated and performed by the R-based script cRacker
(46). Information on subcellular location was taken from SUBA3 (56),
and functional annotation was done according to MAPMAN (57).
ANOVA analysis was used to test for significant differences between
quantitative values on the protein level in the various samples and
treatments. Differences with the p value  .05 in comparison to the
control samples were taken as significant. Statistical assessments on
sterol and metabolite data, such as hierarchical cluster analysis, heat
map, and other data visualizations, were performed with the multiex-
periment viewer software MeV (Version 4.6.2) (58, 59).
RESULTS
The aim of this study was to characterize effects of cyto-
skeletal disruption on protein distribution between low-den-
sity sterol-rich microdomains (as biochemically extracted in
the form of DRM) and general other higher-density membrane
phases (DSM).
Cytoskeletal Disruption Does Not Affect Sterol Content of
the Membrane—Two major phytosterols, sitosterol and
campesterol, were identified and quantified in DRM and DSM
fractions, with generally higher values in DRM fractions. Gen-
erally, these sterols contribute to about 20% of the plasma
membrane lipids. No other typical membrane sterols were
identified but rather organic acids, sugars, alkanes, and many
unidentified compounds containing an alkyl group were char-
acterized in the GC-TOF analysis. In both fractions, a variety
of soluble compounds like ethyl-hexanoic acid, hydroxy-pyr-
idine, octadecane, diethylene glycol, boric acid, or phosphoric
acid were detected (Fig. 2A). These other compounds may
have masked the detection of other lower abundant lipids.
Most of these substances, except for ethanolamine, were
considered as copurifying contaminants since they were not
known to be membrane components.
The cytoskeletal disruption did not result in statistically
significant relative and absolute changes in any of the identi-
fied substances. Both sterols grouped in the same hierarchi-
cal cluster of compounds. The level of sterols in DRM as well
as in DSM fractions remained unaltered in response to cy-
tochalasin D and oryzalin treatment, and as expected, sterol
levels were higher on average in DRM fractions (Fig. 2B).
Thus, we conclude that disruption of actin filaments or dis-
ruption of microtubules does not cause a drastic change in
membrane sterol composition.
General Proteomic Comparison of Collected Fractions—
Detergent-resistant membrane preparations are prone to co-
purifying nonsterol-dependent proteins and may be consid-
ered an enrichment but not a purification of sterol-rich
membrane microdomains (60). In order to robustly establish a
filter for identification of true effects of cytoskeletal disruption
on changes in protein distribution between cellular membrane
phases, reference protein lists of know sterol-dependent pro-
teins, as well as from intracellular membrane proteins and
soluble proteins, were established (60). In the cytochalasin D
experimental series, 557 proteins were identified in DRM frac-
tions (five replicates), a total of 918 proteins were identified in
DSM fractions (four replicates), and 588 and 1,558 proteins
were identified from intracellular membranes (IM, two repli-
cates) and as soluble proteins (SOL, four replicates). For
oryzalin treatment experiments, 449 proteins were identified
in detergent-resistant membranes (five replicates), 996 pro-
teins in detergent-soluble membranes (five replicates), 1,313
proteins in intracellular membranes (four replicates), and 776
proteins as soluble proteins from two biological replicates
(supplemental Fig. 2A). Separation quality of cellular fractions
was confirmed by the fact that in almost all fractions col-
lected, a large number of proteins was identified in a single
fraction only (unique proteins). The largest overlap between
collected fractions was represented by the proteins from
neighboring compartments, for example, 154 or 204 proteins
overlapping between DRM and DSM fractions while only 37 or
one protein was in common for detergent-resistant mem-
branes and soluble fraction (supplemental Fig. 3A).
The identified proteins were then assigned to expected
cellular location based on SUBA3 (56). As expected, in both
drug treatment series, the majority of proteins identified in the
DRM fraction had a plasma membrane location, while pro-
teins identified in the IM fraction largely were of mitochondrial,
plastidial, and endoplasmic reticulum location. The SOL frac-
tion contained the highest amount of soluble proteins (sup-
plemental Fig. 3B). Furthermore, filtering out all proteins that
were found in more than one fraction enriched the fraction-
specific protein groups at an even higher degree (unique
proteins in supplemental Fig. 3B). In further analyses, proteins
were excluded if their abundance was highest in IM or SOL
fractions, even when detected in DRM or DSF fractions. This
filtering procedure was validated in detail in a previous study
(60).
Effects of Cytoskeletal Disruption on Membrane Protein
Distributions—To confirm the specificity of cytochalasin D
and oryzalin treatment on the disruption of actin filaments and
tubulins, respectively, the disappearance of actin or tubulin
protein in the DRM fraction was monitored (Fig. 3A). Cytocha-
lasin D treatment depleted the sample from ACT3 within 30
min of treatment, but a less strong effect was observed for
ACT2. Oryzalin treatment efficiently depleted different tubulin
isoforms from the DRM fraction in a concentration-dependent
manner.
Secondly, specificity of the drug treatment was monitored
using the dual-labeled line for actin and tubulin (Fig. 3B).
Cytochalasin D treatment of 1 h was already enough to sig-
nificantly disrupt the majority of actin filaments, but some
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actin strands still remained visible. Microtubule structures
were not affected by the cytochalasin D treatment. Oryzalin
treatment at a concentration of 5 M for 1 h completely
disintegrated typical microtubule structures, while actin fila-
ments remained intact. Thus, the drug treatments applied in
our experiments specifically affected only one component of
the cytoskeleton.
Cluster analysis of the abundance profiles of DRM proteins
in response to cytochalasin D time course treatment revealed
five major response groups (supplemental Fig. 4A). The larg-
est number of proteins (199 proteins) was found in cluster 3,
with a tendency for an increase of abundance in response to
the treatment. However, these were mainly cytosolic proteins
(66%) and very few plasma membrane proteins (6%). The
cluster with the highest fraction of plasma membrane proteins
(46%) was cluster 1 (144 proteins), with a tendency of de-
creased abundance in the DRM fraction. Clusters with a high
content of cytosolic proteins (clusters 2 and 3) particularly
contained proteins involved in protein synthesis (ribosomal
proteins). Such proteins are known copurifying proteins in
DRM preparations (60). In contrast, clusters 1, 4, and 5, with
high fraction of membrane proteins particularly, were rich in
proteins with transport and signaling functions (these func-
tions made up 18 and 15% of all proteins in cluster 1).
Similarly, oryzalin treatment over the range of concentra-
tions resulted in differential responses of proteins, which
could be separated into five response clusters (supplemental
Fig. 4B) containing 51 (cluster 4) to 113 proteins (cluster 2).
Proteins in cluster 1 showed an increased abundance with
increased concentration of oryzalin, but these were particu-
larly proteins with cytosolic location such as ribosomal pro-
teins. Proteins in two clusters with a high fraction of mem-
brane proteins (62% in cluster 2 and 67% in cluster 4)
displayed a decreased abundance profile in DRM with in-
creasing oryzalin concentration but at different slope. These
clusters were particularly enriched in proteins with signaling
function (3% in cluster 2) or transporters (40% in cluster 4).
However, cytochalasin D or oryzalin treatment of cell cul-
tures did not affect global protein abundance levels and dis-
tribution of proteins identified in the IM and SOL fractions
(supplemental Fig. 5). These findings suggest that the ob-
served drug-induced protein abundance changes for proteins
identified in DRM and DSM fractions were mainly due to local
redistributions within the membrane and not due to global
redistributions between compartments based on disturbed
membrane trafficking.
In order to identify candidate DRM proteins significantly
affected by the cytoskeletal disruptions, three filtering criteria
were applied to the above data set: (i) proteins were required
to be identified in DRM fractions in at least one replicate of
this study, (ii) proteins were required to show significant re-
sponse to drug treatment (ANOVA p value cutoff .05 after
multiple testing (61)), and (iii) have evidence for sterol-de-
pendent membrane location from previous work (22, 60, 62).
Based on these criteria, for cytochalasin D treatment, from the
557 proteins identified in DRM fractions, only 50 proteins had
previously been confirmed also as sterol-dependent proteins
(Fig. 4). For oryzalin treatment, out of 449 proteins identified in
DRM fractions, 66 proteins were also characterized as sterol-
dependent. From this overlap, 22 proteins were found to
significantly display an altered abundance distribution be-
tween DRM and DSF upon cytochalasin D treatment, and 13
proteins were found to significantly change their distribution
profile in response to oryzalin. In most cases, cytoskeleton
disruption, particularly treatment with cytochalasin D, induced
a reduced abundance of proteins in sterol-enriched DRM
fractions with an accompanied increased abundance of that
protein in the sterol-depleted DSM fraction (DRM/DSM ratios
in Table I). This may indicate that these proteins within the
membrane moved from sterol-enriched phases into sterol-
depleted membrane phases, particularly after disruption of
actin filaments.
Out of the 22 proteins with significantly altered distribution
between DRM and DSM upon cytochalasin D treatment (Ta-
ble I; supplemental Fig. 6A), there were eight proteins involved
in membrane transport, four signaling proteins, two oxidases,
two proteins with functions in stress responses, a remorin
protein, and few others with unassigned functions. Among the
13 proteins with significant response to oryzalin, we found
seven transporters, three signaling proteins, a remorin, one
protein involved in abiotic stress responses, and one protein
with unspecified role in plant development (Table I; supple-
mental Fig. 6B). Among all these proteins, nine proteins
showed altered distribution between DRM and DSM upon
both treatments, namely disruption of actin filaments as well
as upon disruption of microtubules (supplemental Fig. 7).
Thereby, six proteins (AHA1, AHA2, ERD4, RLK902,
AT3G61260, AT3G02880) were depleted from DRM in both
drugs, one protein (PATL1) increased in DRM fractions upon
both drugs, and two proteins (AVP1 and VHA-A3) showed
opposite behavior upon actin or microtubule disruption.
Fig. 2. (A) Changes of the level of all identified compounds in GC-MS analysis. Raw intensities obtained by the mass analyzer were normalized
to the internal standard (3-hydroxy-,5-cholestane) that was spiked to every sample before sterol extraction. Intensities of the -sitosterol and
campesterol are highlighted with black squares. (B) Changes of the level of identified sterols in response to applied treatments. Barplots
represent intensities normalized to the internal standard that was used (3-hydroxy-,5-cholestane). No significant changes (ANOVA, p  .05)
in measured sterol levels after (a) cytochalasin D and (b) oryzalin treatment were observed in DRM and DSM fractions. Cytochalasin D in
concentration of 500 nM for 30, 60, 90, and 120 min was applied to cell cultures. Oryzalin was applied to cell cultures for 1 h in increasing
concentration range of 1 M, 2 M, 5 M, and 10 M.
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Cytoskeletal Disruption Affects Activity of Plasma Mem-
brane ATPase—Among the proteins with significantly altered
DRM/DSM distribution profiles (Table I), we identified mem-
bers of the H-ATPase family (AHA1, AHA2, AHA11). To study
the biochemical effect of altered membrane phase recruit-
ment, enzymatic activity assays were carried out in control
and drug-treated cells. Thereby, the activity measurements of
the sterol-rich DRM fractions were compared with activity
measurements of total plasma membrane to relate differences
in activity to differences in submembrane location (Fig. 5).
Cytochalasin D treatment lead to a depletion of all three
isoforms of the H-ATPase from the sterol-rich DRM prepa-
rations (Fig. 5A), and this was accompanied with an increase
in the measured ATPase activity in that fraction, especially in
cytochalasin D treatments of 1 h (Fig. 5B). Activity measured
in total plasma membrane remained unaltered upon the dis-
ruption of actin filaments and was generally lower than in
sterol-rich DRM fractions. These findings suggest that actin
filament disruption leads to recruitment of H-ATPase mole-
cules from more rigid DRM fractions to DSM (supplemental
Fig. 6A, Table I), and this relocation is associated with an
increased activity of the protein remaining in DRM. In con-
trast, oryzalin treatment also removed ATPase isoforms from
the DRM fraction (Fig. 5C), but no accompanied increase in
DSM was observed (supplemental Fig. 6B, Table I). The dis-
ruption of microtubules with oryzalin lead to a decreased
H-ATPase activity in the DRM fraction and increased activity
levels in the whole plasma membrane (Fig. 5D). It seems that
microtubule disruption removed the plasma membrane
ATPases from DRM fractions without associated relocation to
DSM. In general, based on the enzyme activity measurements
in combination with the resulting abundance distribution be-
tween DRM and DSM (Table I), we conclude that alterations in
the location of proteins within membrane phases may signif-
Fig. 3. (A) Response of targeted cytoskeletal components in DRM fraction after applied treatments. Barplots represent scaled intensities of
identified actin isoforms in response to (a) cytochalasin D and (b) tubulin isoforms in response to oryzalin treatment. Cytochalasin D in
concentration of 500 nM for 30, 60, 90, and 120 min was applied to cell cultures. Oryzalin was applied to cell cultures for 1 h in increasing
concentration range of 1 M, 2 M, 5 M, and 10 M. (B) Visualization of cytoskeletal components in dual-labeled A. thaliana seedlings.
Fluorescence images of mCherry-tagged tubulin and GFP-tagged actin in the 5-day-old seedlings in response to either cytochalasin D (c 
500 nM, t  1 h) or oryzalin treatment (c  5 M, t  1 h). Recombinant proteins were expressed under the control of the 35S promoter of the
CM virus. Treatment with cytochalasin D causes an unaltered mCherry fluorescent signal of microtubules while fluorescent pattern of
microfilaments is disturbed and equally distributed among cytoplasm. Upon treatment with oryzalin, seedlings represent an unaltered
fluorescent pattern of GFP-tagged actin while signal from mCherry-tagged tubulin monomers is equally distributed among cytoplasm. Scale
bars represent 20 m.
FIG. 4. (A) Selection of significantly responsive proteins. Candidates were selected out of the list of proteins found in DRM fraction after
treatment with cytochalasin D and oryzalin that overlap with the list of sterol-dependent proteins (14) and demonstrate significant change in
level in comparison to control sample (ANOVA p value  .05). (B) Expression profiles of proteins significantly responsive to cytochalasin D and
oryzalin treatment. Heatmaps of average scaled intensities of treatment significantly responsive proteins. Protein abundance from DRM as well
as from DSM fraction are shown for comparison.
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icantly affect their activity either through changes in abun-
dance or by creating activating/inactivating interaction
environment.
Cytoskeletal Disruption Affects Location of a Receptor Ki-
nase Within the Plasma Membrane—The receptor kinase
AT3G02880 was found to be depleted from DRM upon treat-
ment with cytochalasin D as well as upon treatment with
oryzalin (supplemental Fig. 8A, Table I). The effects of drug
treatment on location of AT3G02880 were analyzed using
Arabidopsis seedlings expression a GFP-fusion under the
CaMV35S promoter (supplemental Fig. 8B). In untreated
seedlings, AT3G02880 showed more or less uniform distribu-
tion across the plasma membrane. Interestingly, the uniform
distribution of fluorescent signal was exempt in line-shaped
regions, resembling the cellular pattern of microtubule
strands. We suggest that these exempt darker areas follow
the distribution of microtubules below the membrane bi-
layer. This statement is supported by the finding that we did
not record such distribution in oryzalin-treated seedlings,
whereas it was still visible after treatment with cytochalasin
D. Occasionally, locations in punctate patterns (arrows in
supplemental Fig. 8C) were visible.
Treatment of cells with cytochalasin D did not lead to large
overall changes in location pattern of AT3G02880 but en-
hanced the appearance of the punctate location. Treatment
with oryzalin resulted in a more uniform pattern, losing the
cytoskeleton negative print in the location pattern and result-
ing in smaller punctate structures.
Cytoskeletal Disruption Affects Location of Remorins—
Remorins are plasma membrane proteins that were shown to
TABLE I
Summary of proteins with increased or decreases abundance in DRM fractions upon cytoskeletal disruption with cytochalasin D or oryzalin
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locate to sterol-rich membrane microdomains using cell bio-
logical and biochemical approaches (9, 63), and they are
highly enriched in DRM preparation (22, 60, 63). In our exper-
iments, cytoskeletal disruptions led to altered distributions of
remorin AtREM1.2 between DRM and DSM (Fig. 6A). These
findings from the large-scale proteomic approach were con-
firmed by protein gel blot analysis of four fractions across
the sucrose gradient separating sterol-rich DRM from ste-
rol-depleted DSM (Fig. 6B). Particularly, when actin fila-
ments were disintegrated by cytochalasin D treatment,
remorin abundance clearly decreased in DRM fractions and
increased in DSM. Disruption of microtubules by oryzalin
also led to a depletion of remorins AtREM1.2 and AtREM1.3
from DRM, but the accompanied increase in DSM was less
prominent compared with the observations in cytochalasin
D treatment (Fig. 6C). Location of AtREM1.2 in untreated
Arabidopsis seedlings was found in punctate patterns, as
observed previously (9, 63). Treatment with cytochalasin D
completely disrupted this punctate location pattern to a
more uniform distribution with smaller punctate patterns of
lower intensity. In contrast, treatment with oryzalin en-
hanced punctate location of AtREM1.2 to bigger dots of
higher intensity.
DISCUSSION
This work aimed at a systematic analysis of the role of
cytoskeletal components for sterol-rich membrane phase
composition based on treatments with actin- or tubulin-dis-
rupting agents. We used a proteomic screening approach to
identify cytoskeleton-dependent proteins among established
microdomain proteins. Enzyme assays and microscopy were
then used to relate the biochemical findings to protein activ-
ities and location.
As an important prerequisite for the experimental design
and the conclusions drawn, using the actin and microtubule
dual-labeled line, we confirmed that the conditions used for
the treatments affect only the respective cytoskeletal compo-
nent and not the other. Thus, we may be able to differentiate
between specific role of actin filaments or microtubules for
membrane phase composition in plants.
Cytoskeleton and Protein Trafficking—All the plasma mem-
brane constituents undergo a mechanism called secretion by
which proteins, lipids, and other molecules are trafficked and
delivered to their final destinations. Usual migration of pro-
teins starts in the endoplasmic reticulum (ER) where they are
synthesized. Then they are moved into the Golgi-apparatus
where they obtain modifications (reviewed in (64)). Sorting of
FIG. 5. Effect of cytoskeletal disruption on plasma membrane ATPases. (A) Protein abundance distribution of H-ATPase isoforms
measured by mass spectrometric analysis in response to the treatments of cytochalasin D and oryzalin. (B) Enzymatic measurement of ATPase
activity in DRM and total plasma membrane (PM) in response to cytochalasin D and oryzalin treatment, respectively. Activity measurements
were carried out with the use of malachite green enzyme assay and samples were normalized to the total protein content. Cytochalasin D in
concentration of 500 nM for 30, 60, 90, and 120 min was applied to cell cultures. Oryzalin was applied to cell cultures for 1 h in increasing
concentration range of 1 M, 2 M, 5 , and 10 M.
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FIG. 6. Remorins and cytoskeleton. (A) Protein abundance patterns for remorin 1.2 as revealed by mass spectrometric analysis. (B)
Schematic diagram of the sucrose gradient separating sterol-rich DRM and sterol-depleted DSF and indicated fractions sampled for analysis.
Fraction 1 corresponds to the DRM fraction and fraction 4 is the DSM. (C) Protein gel blots of AtREM1.2 and AtREM1.3 across the fractions
collected in the sucrose gradient in control samples, as well as cells treated with cytochalasin D and oryzalin. Intensity profiles are the
reflections of the obtained strength of the bands’ visibility (A, B, C - experiments performed on cell cultures as described in Methods). (D)
Distribution of AtREM1.2:YFP under native promoter in untreated seedlings, as well as in response to cytochalasin D and oryzalin treatment.
Treatment of seedlings with cytochalasin D resulted in loss of punctate location at the plasma membrane. Treatment of seedlings with oryzalin
resulted in enhancement of larger punctate structures. Scale bars represent 20 m.
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proteins occurs at the trans-Golgi network from where the
carriers are being transported to the targeted compartment.
It is likely that because of the close proximity, the ER and
Golgi organelles do not require cytoskeletal elements to ex-
change carrier vesicles with each other. This was clearly
proven by fluorescence recovery in the Golgi after photo-
bleaching of fluorescent protein fusions of Golgi-localized
proteins in the presence of the trafficking inhibitor brefeldin A
(65, 66), in the presence of microtubule-disrupting agents (65,
66) and in cells treated with actin-disrupting agents (67). Thus,
short distance membrane flow in the early secretory pathway
is not impaired in the absence of functional cytoskeletal com-
ponents. The secretory route from ER and trans-Golgi net-
work to the destination membranes has not been revealed in
detail. It is also unknown if trafficking to the plasma membrane
is a direct process or if it includes some intermediate compart-
ments endosomal compartments (68, 69). Although there are
indications that the trans-Golgi network to plasma membrane
trafficking involves exocyst complex (70), exosomes, and prob-
ably multivesicular bodies (71), it still needs to be revealed if the
cytoskeleton is necessary for this process.
In contrast, participation of microtubules and actin fila-
ments in endocytosis from the plasma membrane is quite well
documented (72). Actin may create aided invaginations by
specific protein–protein interactions (73–75). Importance of
actin as part of the endocytotic machinery was also evaluated
with the use of chemical inhibitors of actin polymerization (76).
Also, microtubules were proven to play important role in both
clathrin- and nonclathrin-mediated endocytosis (77).
A question that arises while analyzing the data set obtained
here is whether the observed effects on the composition of
detergent-resistant membrane fractions could be a result of a
disturbed protein and membrane trafficking from/to the ER
and Golgi apparatus. If the common trafficking pathways to
the plasma membrane were disturbed, we would expect to
observe some large global changes in the composition of
different intracellular fractions (IM, SOL; see Fig. 1). For ex-
ample, if vesicles carrying cargo destined to the plasma mem-
brane or extracellular matrix are trapped within the cytoplasm,
endoplasmic reticulum, Golgi apparatus or vacuole, a drop in
protein abundance should be observed in target compart-
ments, and an increased abundance is expected either in
intracellular membrane fraction (IM) or in fraction of soluble
proteins (SOL). However, the cytoskeletal disruption by cy-
tochalasin D did not induce major global changes in protein
abundances of proteins identified in the IM and SOL fractions
(supplemental Fig. 5). This may indicate that observed
changes in the abundance of specific proteins in the deter-
gent-resistant membrane fraction was likely not a result of
generally disturbed membrane trafficking or cell metabolism
but due to rearrangements within the plasma membrane
phases. Oryzalin treatment induced a large scatter of abun-
dances of proteins identified in IM fractions, indicating a pos-
sible contribution of tubulins in protein trafficking from/to
DRM fractions.
Proteins Significantly Affected by Cytoskeletal Disrup-
tion—By application of the filtering criteria, 22 proteins previ-
ously defined as sterol dependent showed a significant relo-
cation in response to cytochalasin D and 13 proteins
rearranged in response to oryzalin and nine proteins showed
a significant response to both actin and microtubule disrup-
tion. These nine proteins were also previously identified as
proteins with stimulus-induced abundance changes in DRM
fractions either in response to flagellin (10) or during cold
acclimation (78).
We observed that in response to cytochalasin D (actin
filament disruption), 86% of the proteins were reduced in the
DRM fraction, often displaying an associate increased abun-
dance in the DSM fraction (Table I). In case of oryzalin treat-
ment (microtubule disruption), a reduced abundance in DRM
was observed only in 54% of the cases, and often there was
no associated increase in protein abundance in DSM fractions
(Table I). Thus, disruption of actin and tubulin resulted in
differential distribution between the DRM and DSM fractions,
although in both cases a depletion of DRM fractions was
observed.
AVP1 (AT1G15690) is a type I H-pyrophosphatase and
observed with depletion from DRM and associated enrich-
ment in DSM in response to cytochalasin D treatment and
enrichment in DRM fractions in response to oryzalin treat-
ment. Activity of AVP1 depends on cytosolic level of potas-
sium and is moderately sensitive to inhibition by calcium (79).
Overexpression of AVP1 also enhances nutrient uptake by
affecting the abundance and activity of the plasma membrane
H-ATPase (80). Initially, AVP1 was considered to be a bona
fide vacuolar marker (79, 81). However, recent studies with
the use of double epifluorescence and immunogold labeling
experiments showed the colocalization of AVP1 and plasma
membrane located aquaporin PIP1 in plasma membrane from
Arabidopsis (82). In the protein–protein interaction network of
the proteins with altered DRM abundance upon cytoskeletal
disruption, AVP1 seems to take a hub position connecting
cytoskeletal elements with other ATPases such as AHA1,
AHA2, AHA11, or VHA-A3 (supplemental Fig. 7).
AHA1 (AT2G18960) and AHA2 (AT4G30190) are the two
most dominant plasma membrane proton pumps that gener-
ate proton gradient across the membrane in an ATP-depend-
ent manner. Their activity results in creation of proton motive
force that is used by other membrane components as a
source of energy for their functions. Phosphorylation was
found to be crucial mechanism for regulation of both AHA1
and AHA2 (40, 83–85). AHA1 and AHA2 were both identified
as DRM constituents in several proteomic analyses (62, 78)
and were additionally found as significantly enriched in DRM
fractions after flg22 treatment (10). Cytoskeletal disruption
lead to a depletion of AHA1 and AHA2 from DRM fractions but
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enzymatic assays revealed opposite effects of relocation
within the membrane on H-ATPase activity.
Remorins—The remorin AtREM1.2 (AT3G61260) was iden-
tified as significantly responsive to actin as well as microtu-
bule disruption. In both cases, a decreased abundance in
DRM fraction was observed, but only when actin filaments
were disrupted, REM1.2 showed an accompanied increased
abundance in DSM. Remorins are considered as membrane
microdomain markers, and they were repeatedly identified in
DRM fractions by proteomic analyses (10, 22, 60, 62, 78).
Immunolocalization, as well as GFP-tagging, revealed that
remorins from group 1b (86) to which AtREM1.2 belongs,
accumulate in distinct patches within plasma membrane.
Also, in Medicago truncatula, MtSYMREM1 localizes in immo-
bile domains in the plasma membrane of root hair cells (87).
Here, we generally confirmed the patchy membrane location
of AtREM1.2. Recent evidence, however, indicates that remo-
rin location is quite complex and can exhibit isoform-specific
patterns restricted to organs or developmental stages (9). The
patchy location of AtREM1.2 in hypocotyls was abolished
upon actin filament disruption, leading to uniform fluores-
cence with exception of the regions where microtubule
strands run below the membrane bilayer.
We conclude that intact actin filaments are necessary for
AtREM1.2 location to the patchy structures of membrane
microdomains. Actin-dependent patchy membrane location
has been described in mammalian cells also for acetylcholine
receptor (in the membrane of Chinese hamster ovary that was
lost when intracellular components including cytoskeleton
were removed) (88).
Enhancement of patchy AtREM1.2 patterns was observed
upon disruption of microtubules (Fig. 6), but the distance
between the observed patches became larger. It therefore
seems that disturbance of microtubules resulted in relocaliza-
tion of remorin containing membrane phases or microdo-
mains within the plasma membrane.
Contrasting Effects of Actin and Tubulin Disruption—Dis-
ruption of actin filaments or disruption of microtubules struc-
tures in many cases resulted in differential responses of the
respective proteins. One general finding was that, although
both drug treatments resulted in depletion of candidate pro-
teins from DRM fractions, only for cytochalasin D treatment a
respective increase in abundance of these proteins in the
DSM was observed (supplemental Table 1). These observa-
tions were made initially by proteomic analysis of cell suspen-
sion cultures and then confirmed using microscopy on young
seedlings. We consider the results from both systems as
similar and comparable since general membrane and cyto-
skeleton interaction effects were studied and no specific re-
sponses in context of differentiation and cell contact. How-
ever, the cytoskeleton may be particularly important in
inducing polar protein location in differentiated cells.
Treatment of the cells and seedlings with oryzalin also
resulted in decreased abundance of proteins in DRM frac-
tions, but the expected increased abundance in DSM was not
measured (supplemental Table 2). These opposite effects of
actin and microtubule disruption were confirmed by activity
measurements for H-ATPase isoforms (Fig. 5), for location of
receptor kinase AT3G02880 (supplemental Fig. 8), and for
remorin AtREM1.2 (Fig. 6). The effects of actin disruption on
remorin protein membrane location were reproduced using
latrunculin B as another actin-disrupting agent (supplemental
Fig. 9). Thereby, disruption of actin as well as the disappear-
ance of the spotty localization pattern for remorin were similar
as under cytochalasin D treatment.
In general, it needs to be kept in mind that the plasma
membrane is a very dynamic structure. There is evidence that
in plants multiple types of membrane domains with distinct
composition coexist at the same time (9), and some of these
could be formed in a stimulus-dependent manner or when the
specific changes in lipid or protein composition occurred (87).
Thus, biochemical approaches as carried out here by using
changes in composition of a single biochemical fraction (here
DRM) and the distribution of proteins between fractions (DRM
and DSM) as readout for dynamic relocation of proteins within
the membrane will not be able to distinguish these different
specific microdomains observed in vivo. However, the ap-
proach validated identification of candidate proteins that un-
dergo dynamic submembrane locations.
CONCLUSIONS
Various proteins found with altered distributions between
DRM and DSM upon cytoskeletal disruption could be con-
firmed through resulting differences in activity or location
patterns. Based on our results, we suggest that actin fila-
ments are necessary for dynamic movement of proteins be-
tween different membrane phases. The effects of actin were
confirmed by similar location patterns using two different
actin-disrupting agents (latrunculin B and cytochalasin D). We
further suggest that microtubules are not necessarily impor-
tant for formation of microdomains as such, but they control
the density and size of these structures (supplemental Fig.
10). Thus, if density and size of membrane microdomains
changed within a cell (as, for example, observed for remorin),
this could also result in an overall lower abundance of these
microdomain proteins in membrane preparations and in DRM
fractions. Our suggestion that microtubules may be respon-
sible for control of size and density of membrane microdo-
mains is further supported by the fact that more proteins with
increased DRM/DSM ratio were found upon microtubule dis-
ruption treatment compared with treatment with actin-dis-
rupting agents.
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